Good Evening Market Enthusiast,
 

We’ve been working non-stop to deliver back-to-back-to-back biotech wins, and we’ve just uncovered another exciting one that’s positioned for potentially big moves.
 

Here’s why you should be watching closely:
 

🧪 Breakthrough Science

This company has teamed up with Massachusetts General Hospital for five Phase II clinical trials targeting major conditions like Alzheimer’s, bipolar disorder (BD), major depressive disorder (MDD), and PTSD—impacting over 43 million Americans.
 

💡 Innovative Treatments

Their lead candidate aims to deliver the benefits of lithium therapy with fewer side effects and a 20% lower daily dosage, offering a safer alternative for patients.
 

🧬 Alzheimer’s Revolution

Their second candidate takes an active immunotherapy approach to Alzheimer’s, training the immune system to fight harmful brain plaques—potentially providing long-lasting benefits.

With only around 4 million shares available and a strong financial backing for the next 18 months, this biotech is positioned for serious price movement.
 

🚨 Don’t miss the chance to dive deeper into this company—check it out now!
 

To Your Success,

Max Masters

Co-founder, Market Tips Newsletter

Data is provided from third-party sources and Market Tips is not responsible for its accuracy. Make sure to always do your own research and due diligence on any day and swing profile I bring to your attention. Any emojis used do not have a specific defined meaning, and may be used inconsistently. We do not provide personalized fin.ancial advice, are not finan.cial advisors, and our opinions are not suitable for all in.vest.ors. Please review our full disc.laim.er here.